Impact of body mass index (BMI) and weight changes on recurrence and survival in stage III colon cancer (CC).

Authors

null

Joanna Vergidis

British Columbia Cancer Agency

Joanna Vergidis , Sina Alipour , Winson Cheung

Organizations

British Columbia Cancer Agency, University of British Columbia

Research Funding

No funding sources reported

Background: Research suggests that physical activity can lower the risk of relapse and mortality from CC. However, it is unclear if such benefits are mediated through an effect on weight. Our aims were to (1) evaluate the impact of pre-treatment BMI on recurrence and survival in early stage CC, (2) examine how changes in weight from baseline may affect outcomes, and (3) explore if the effects of different body compositions are modified by adjuvant therapy (AT). Methods: Patients (pts) diagnosed with stage III CC from 2006 to 2008, evaluated at any 1 of 5 cancer centers in British Columbia, and who had their weights measured serially throughout their AT period were reviewed. Using Cox proportional hazards models, we compared outcomes among (a) BMI<25 [normal] vs. 25-30 [overweight] vs. >30 [obese] and (b) weight increase or decrease of < vs. >/=5% and < vs. >/=10%, while controlling for confounders. Results: A total of 821 pts were included: median age was 65 years, 50% were men, and 83% were ECOG 0/1. At baseline, 43, 37, and 20% were normal, overweight, and obese, respectively. Compared to pts with normal BMI, those who were overweight or obese did not show an increased risk of recurrence (HR 0.81, 95%CI 0.42-1.58 and HR 1.09, 95%CI 0.48-2.51, respectively, p trend=0.74) or death (HR 0.54, 95%CI 0.26-1.13 and HR 0.62, 95%CI 0.22-1.74, respectively, p trend=0.24). A number of pts experienced weight gain or loss during their AT period, but none of these weight changes affected outcomes (Table). Receipt of AT did not modify the effects of BMI or weight change on outcomes. In Cox models, advanced age and poor performance status were the main factors that consistently correlated with an increased risk of recurrence and death (p<0.05). Conclusions: Neither baseline BMI nor short-term weight changes during AT appear to affect outcomes in stage III CC. Physical activity likely exerts its benefit on relapse and survival by influencing long-term weight changes or by alternative mechanisms.

% of cohort Recurrence
Death
HR P value HR P value
Wt gain
<5% 49.6 1.0 0.91 1.0 0.76
≥5% 50.4 1.04 0.90
<10% 81.3 1.0 0.42 1.0 0.96
≥10% 18.7 0.75 0.98
Wt loss
<5% 87.6 1.0 0.97 1.0 0.64
≥5% 12.4 0.98 1.42
<10% 95.5 1.0 0.14 1.0 0.86
≥10% 4.5 0.41 0.83

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2013 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon and Rectum

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Prevention, Diagnosis, and Screening

Citation

J Clin Oncol 31, 2013 (suppl 4; abstr355)

DOI

10.1200/jco.2013.31.4_suppl.355

Abstract #

355

Poster Bd #

A23

Abstract Disclosures

Similar Abstracts

First Author: David Viñal

First Author: Joanna Vergidis